XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Equity Compensation Plan Information

Equity Compensation Plan Information as of September 30, 2025:

 

   Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
(a)
  

Weighted – average
exercise price of

outstanding options,
warrants and rights
(b)

  

Number of securities
remaining available

for future issuances

under equity
compensation plans
(excluding securities

reflected in column
(a) (c)

 
Equity Compensation Plans Approved by Security Holders   3,150,000   $0.0399    21,680,882 
Equity Compensation Plans Not Approved by Security Holders   37,801,503    0.0195     
Total   40,951,503   $0.0297    21,680,882 
Schedule of Valuation Assumptions of Options

The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

  

   Nine Months ended September 30, 
   2025   2024 
Expected volatility   172.0% - 346.4%   172.0346.4%
Expected term   1.55.0 Years    1.55.0 Years 
Risk-free interest rate   0.16% - 4.64%   0.16% - 4.64%
Forfeiture rate   0.17%   0.17%
Schedule of Outstanding Stock Option Activity

A summary of the status of the Company’s outstanding stock options as of September 30, 2025 and December 31, 2024 and changes during the periods ending on such dates is as follows:

  

   Number of  

Weighted

Average

Exercise

  

Weighted

Average

Remaining

Contractual

  

Aggregate

Intrinsic

 
   Options   Price   Life in Years   Value 
Outstanding at December 31, 2024   238,439,167   $0.0362    1.43                
Granted   -    -           
Forfeited   (170,999,530)   0.0379           
Exercised   -    -           
Cancelled   -    -           
Outstanding – December 31, 2024   67,439,637   $0.0360    1.43      
Exercisable – December 31, 2024   41,057,753   $0.0211    1.33   $- 
                     
Granted   -    -           
Forfeited   (1,475,000)   0.0379           
Exercised   -    -           
Expired   (35,295,237)               
Cancelled   -    -           
Outstanding – September 30, 2025   30,669,400   $0.043268    1.07      
Exercisable – September 30, 2025   7,059,400   $0.0531    1.106   $- 
Schedule of Exercise Price of Employee Stock Options Outstanding

The following table summarizes information about employee stock options outstanding at September 30, 2025.

 

Range of Exercise Price  Number
outstanding
at June 30, 2025
   Weighted
average
remaining
Life
   Weighted
average
exercise
price
   Number
exercisable
at June 30, 2025
   Weighted
average
exercise
price
   Weighted
average
remaining
life
 
$ 0.0180 - $0.0225 ( Expired)   0    0.00   $0.0180    0.00   $0.0180    0.00 
$ 0.0229 - $0.0325   50,000    1.12   $0.0302    50,000   $0.0302    1.12 
$ 0.0360 - $0.0425   22,659,400    1.05   $0.0398    4,659,400   $0.0395    .92 
$ 0.0440 - $0.0531   7,960,000    1.17   $0.0531    2,350,000   $0.0530    .94 
Outstanding options   30,669,400    1.07    0.0432    7,059,400    0.0439    0.93 
Schedule of Warrant Activity

A summary of the Company’s warrants as of December 31, 2024 and changes during the nine months ended September 30, 2025 is presented below:

  

   Number of  

Weighted

Average

Exercise

  

Weighted

Average

Remaining

Contractual

  

Aggregate

Intrinsic

 
   Warrants   Price   Life in Years   Value 
Outstanding – December 31, 2024   25,684,521   $0.0247    0.93   $24,000 
Granted   -             
Exercised                 
Forfeited or Expired   25,684,521            - 
Outstanding – September 30, 2025   -   $-        - 
Exercisable – September 30, 2025   -   $-       $-